942155-72-8Relevant academic research and scientific papers
NOVEL PSEUDOGLYCOLIPID AND USE THEREOF
-
Page/Page column 15-16, (2009/12/27)
The present invention provides a novel pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the novel pseudoglycolipid and the like. A compound represented by the foll
RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines
Tashiro, Takuya,Nakagawa, Ryusuke,Hirokawa, Takatsugu,Inoue, Sayo,Watarai, Hiroshi,Taniguchi, Masaru,Mori, Kenji
experimental part, p. 6360 - 6373 (2011/02/26)
Cyclitol [RCAI-37 (1), 59 (5), 92 (7), and 102 (2)] and carbasugar analogs [RCAI-56 (3), 60 (4), and 101 (6)] of KRN7000 were synthesized through coupling reactions of the corresponding cyclitol or carbasugar derivatives with a cyclic sulfamidate (9) as t
RCAI-56, a carbocyclic analogue of KRN7000: its synthesis and potent activity for natural killer (NK) T cells to preferentially produce interferon-γ
Tashiro, Takuya,Nakagawa, Ryusuke,Hirokawa, Takatsugu,Inoue, Sayo,Watarai, Hiroshi,Taniguchi, Masaru,Mori, Kenji
, p. 3343 - 3347 (2008/02/07)
RCAI-56 (3), a carbocyclic analogue of KRN7000 (1) was synthesized through an efficient coupling of a carba-α-d-galactose derivative 11 with cyclic sulfamidate derivative 13 of phytosphingosine to give 15. Carbasugar derivative 11 was prepared by starting
